Literature DB >> 9776953

Specific issues related to developing, disseminating, and implementing pediatric practice guidelines for physicians, patients, families, and other stakeholders.

H Bauchner1, L Simpson.   

Abstract

OBJECTIVE: To describe ways in which medical information should be developed and disseminated, focusing on pediatric practice guidelines as an example of one type of information. PRINCIPAL
FINDINGS: The methodology of guideline development is well known and has been previously reviewed. Guideline development poses problems for many medical specialties, but particularly for pediatrics, because (1) few diseases are prevalent, (2) only limited randomized controlled trials have been conducted with respect to specific diagnostic and therapeutic options, and (3) clinicians often are dealing with patient surrogates--parents--rather than with the actual patient. Patient and family involvement in guideline development and dissemination has been limited and may affect the likelihood that guidelines will be adopted and subsequently improve child health outcomes. The science of dissemination, including guidelines and other information, is poorly developed. Little is known about the most effective ways to ensure that guidelines reach clinicians and are adopted. Finally, the effect of guidelines on child health outcomes is itself uncertain. RECOMMENDATIONS: (1) Research efforts should focus on guideline dissemination and adoption. (2) The effect of guideline implementation on health outcomes needs to be better understood. (3) Parents should be more involved in guideline dissemination and adoption.

Entities:  

Mesh:

Year:  1998        PMID: 9776953      PMCID: PMC1070308     

Source DB:  PubMed          Journal:  Health Serv Res        ISSN: 0017-9124            Impact factor:   3.402


  20 in total

Review 1.  Words without action? The production, dissemination, and impact of consensus recommendations.

Authors:  J Lomas
Journal:  Annu Rev Public Health       Date:  1991       Impact factor: 21.981

2.  Management of the young febrile child: a continuing controversy.

Authors:  H Bauchner; S I Pelton
Journal:  Pediatrics       Date:  1997-07       Impact factor: 7.124

3.  Clinical decision making: from theory to practice. Designing a practice policy. Standards, guidelines, and options.

Authors:  D M Eddy
Journal:  JAMA       Date:  1990-06-13       Impact factor: 56.272

4.  Practice guidelines and practicing medicine. Are they compatible?

Authors:  R H Brook
Journal:  JAMA       Date:  1989-12-01       Impact factor: 56.272

5.  Some reservations about clinical guidelines.

Authors:  A Hopkins
Journal:  Arch Dis Child       Date:  1995-01       Impact factor: 3.791

6.  Changing physicians' practices.

Authors:  P J Greco; J M Eisenberg
Journal:  N Engl J Med       Date:  1993-10-21       Impact factor: 91.245

7.  Effect of clinical guidelines on medical practice: a systematic review of rigorous evaluations.

Authors:  J M Grimshaw; I T Russell
Journal:  Lancet       Date:  1993-11-27       Impact factor: 79.321

8.  Internists' attitudes about clinical practice guidelines.

Authors:  S R Tunis; R S Hayward; M C Wilson; H R Rubin; E B Bass; M Johnston; E P Steinberg
Journal:  Ann Intern Med       Date:  1994-06-01       Impact factor: 25.391

9.  Parents' versus physicians' values for clinical outcomes in young febrile children.

Authors:  M S Kramer; J Etezadi-Amoli; A Ciampi; S M Tange; K N Drummond; E L Mills; M L Bernstein; D G Leduc
Journal:  Pediatrics       Date:  1994-05       Impact factor: 7.124

10.  Decline of childhood Haemophilus influenzae type b (Hib) disease in the Hib vaccine era.

Authors:  W G Adams; K A Deaver; S L Cochi; B D Plikaytis; E R Zell; C V Broome; J D Wenger
Journal:  JAMA       Date:  1993-01-13       Impact factor: 56.272

View more
  2 in total

1.  Improving the quality of healthcare for children: implementing the results of the AHSR research agenda conference.

Authors:  N Halfon; M Schuster; W Valentine; E McGlynn
Journal:  Health Serv Res       Date:  1998-10       Impact factor: 3.402

2.  Reconsidering patient participation in guideline development.

Authors:  Hester M van de Bovenkamp; Margo J Trappenburg
Journal:  Health Care Anal       Date:  2008-12-20
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.